COST-EFFECTIVENESS OF THROMBOPROPHYLAXIS WITH ENOXAPARIN FOR GENERAL SURGERY PATIENTS IN CHINA

被引：0
|
作者：
Zhao, G. [1 ]
Gu, X. H. [2 ]
Bu, J. [3 ]
Lin, H. W. [4 ]
Wu, B. [4 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gen Surg, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Resp, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cardiol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Pharm,Med Decis & Econ Grp, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV62
引用
收藏
页码：A270 / A270
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of enoxaparin as thromboprophylaxis in acutely ill medical patients in Spain
    Nuijten, MJC
    Villar, FA
    Kosa, J
    Nadipelli, V
    Rubio-Terrés, C
    Suarez, C
    VALUE IN HEALTH, 2003, 6 (02) : 126 - 136
  • [2] Extended Duration Thromboprophylaxis Cost-Effectiveness in Abdominal Surgery
    Iannuzzi, James C.
    Rickles, Aaron S.
    Dolan, James G.
    Fleming, Fergal
    Monson, John R.
    Noyes, Katia
    GASTROENTEROLOGY, 2013, 144 (05) : S1047 - S1048
  • [3] Cost-effectiveness of Prolonged Thromboprophylaxis After Cancer Surgery
    Bradley, C.
    Brasel, K.
    Miller, J.
    Pappas, S.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 29 - 29
  • [4] Cost-Effectiveness of Prolonged Thromboprophylaxis After Cancer Surgery
    Ciarán T. Bradley
    Karen J. Brasel
    Jessica Jane Miller
    Sam G. Pappas
    Annals of Surgical Oncology, 2010, 17 : 31 - 39
  • [5] Cost-Effectiveness of Prolonged Thromboprophylaxis After Cancer Surgery
    Bradley, Ciaran T.
    Brasel, Karen J.
    Miller, Jessica Jane
    Pappas, Sam G.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (01) : 31 - 39
  • [6] COST-EFFECTIVENESS ANALYSIS OF EXTENDED THROMBOPROPHYLAXIS IN HIP FRACTURE: FONDAPARINUX VERSUS ENOXAPARIN
    Francisco Javier, Carrera Hueso
    Auxiliadora, Ramon Barrios
    Jose Adolfo, Carrera Hueso
    Jaime Eduardo, Poquet Jornet
    ATENCION FARMACEUTICA, 2010, 12 (03): : 144 - 155
  • [7] A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting
    Yun Bao
    Gang Zhao
    Shuli Qu
    Tengbin Xiong
    Xingxing Yao
    Bin Wu
    Clinical Drug Investigation, 2020, 40 : 161 - 171
  • [8] A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting
    Bao, Yun
    Zhao, Gang
    Qu, Shuli
    Xiong, Tengbin
    Yao, Xingxing
    Wu, Bin
    CLINICAL DRUG INVESTIGATION, 2020, 40 (02) : 161 - 171
  • [9] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN SPAIN
    Diamantopoulos, A.
    Forster, F.
    Brosa, M.
    Lees, M.
    Pinol, C.
    Febrer, L.
    VALUE IN HEALTH, 2008, 11 (06) : A533 - A533
  • [10] THE COST-EFFECTIVENESS OF ENOXAPARIN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING MAJOR SURGERY IN EGYPT
    Farag, A.
    Moety, Abdel H.
    Hassan, L.
    Pathak, P.
    Lamotte, M.
    Levorsen, A.
    VALUE IN HEALTH, 2019, 22 : S895 - S895
12345